These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 6330386)

  • 21. Live attenuated varicella virus vaccine. Efficacy trial in healthy children.
    Weibel RE; Neff BJ; Kuter BJ; Guess HA; Rothenberger CA; Fitzgerald AJ; Connor KA; McLean AA; Hilleman MR; Buynak EB
    N Engl J Med; 1984 May; 310(22):1409-15. PubMed ID: 6325909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group.
    Tsolia M; Gershon AA; Steinberg SP; Gelb L
    J Pediatr; 1990 Feb; 116(2):184-9. PubMed ID: 2153790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization of healthy adults with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
    J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a live varicella vaccine in children with acute leukemia or other malignant diseases.
    Izawa T; Ihara T; Hattori A; Iwasa T; Kamiya H; Sakurai M; Takahashi M
    Pediatrics; 1977 Dec; 60(6):805-9. PubMed ID: 202915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of live attenuated varicella vaccine to children with cancer before starting chemotherapy.
    Cristófani LM; Weinberg A; Peixoto V; Boas LS; Marques HH; Maluf Júnior PT; Pannuti C; Oselka GW; Amato Neto V; Odone-Filho V
    Vaccine; 1991 Dec; 9(12):873-6. PubMed ID: 1667345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varicella vaccine in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Yeung CY; Liang DC
    Pediatr Hematol Oncol; 1992; 9(1):29-34. PubMed ID: 1313688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella vaccine (VARIVAX) in healthy children and adolescents: results from clinical trials, 1987 to 1989.
    White CJ; Kuter BJ; Hildebrand CS; Isganitis KL; Matthews H; Miller WJ; Provost PJ; Ellis RW; Gerety RJ; Calandra GB
    Pediatrics; 1991 May; 87(5):604-10. PubMed ID: 1850506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live attenuated varicella vaccine.
    Gershon AA
    Pediatr Ann; 1984 Sep; 13(9):653-6. PubMed ID: 6093030
    [No Abstract]   [Full Text] [Related]  

  • 31. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of one vs. two injections of Oka/Merck varicella vaccine in healthy children.
    Ngai AL; Staehle BO; Kuter BJ; Cyanovich NM; Cho I; Matthews H; Keller P; Arvin AM; Watson B; White CJ
    Pediatr Infect Dis J; 1996 Jan; 15(1):49-54. PubMed ID: 8684876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A live varicella vaccine in a pediatric community.
    Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
    Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Varicella vaccination].
    Heidl M; Scholz H
    Padiatr Grenzgeb; 1990; 29(1):31-6. PubMed ID: 2160635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.